Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA
Ferreira, Alberto, Sagkriotis, Alexandros, Olson, Melvin, Lu, Jingsong, Makin, Charles, Milnes, Fran
Published in PloS one (24.07.2015)
Published in PloS one (24.07.2015)
Get full text
Journal Article
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
Johnston, Robert L., Carius, Hans-Joachim, Skelly, Adrian, Ferreira, Alberto, Milnes, Fran, Mitchell, Paul
Published in Advances in therapy (01.03.2017)
Published in Advances in therapy (01.03.2017)
Get full text
Journal Article
Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence
Chakravarthy, Usha, Bezlyak, Vladimir, Sagkriotis, Alexandros, Griner, Ray, Skelly, Adrian, Boyer, David S, Milnes, Fran
Published in Ophthalmology retina (01.01.2019)
Published in Ophthalmology retina (01.01.2019)
Get more information
Journal Article